Natural Compounds as PI3K-α Inhibitors for Breast Cancer
Author Information
Author(s): Mili Ajay, Birangal Sumit, Giridhar Jyothi, Nandakumar Krishnadas, Lobo Richard
Primary Institution: Manipal Academy of Higher Education, Manipal
Hypothesis
The research aimed to identify natural compounds that can inhibit mutant and specific isoforms of PI3K-α to prevent tumor progression.
Conclusion
Three natural compounds were identified as promising PI3K-α inhibitors, showing potential for breast cancer treatment with fewer side effects than conventional medicines.
Supporting Evidence
- PI3K-α mutation is responsible for about 29% of breast cancers.
- Natural products have shown potential in targeting multiple pathways involved in cancer progression.
- Three compounds demonstrated significant stability and interaction with PI3K-α in molecular dynamics simulations.
Takeaway
Scientists found some natural substances that might help stop a type of breast cancer by blocking a specific protein that helps tumors grow.
Methodology
The study used e-pharmacophore modeling, molecular docking, and molecular dynamics simulations to identify and evaluate natural compounds as PI3K-α inhibitors.
Limitations
The study's findings need validation through proper in vivo and in vitro models.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website